Abstract
Autotransfusion of shed mediastinal blood after cardiac surgery has been used to reduce risks related to homologous blood transfusions. To document the efficacy and safety of autotransfusion, we compared clinical findings of 80 patients receiving shed mediastinal blood (autotransfusion group) with those of the control group of 52 patients. The amount of the autotransfusion was limited to 800 ml, given the potentially harmful effects of shed blood transfusion. The mean transfused shed volume was 314 ± 236 ml (S.D.). The serum levels of FDP-E, D-dimer and TAT after autotransfusion were higher in the autotransfusion group than in the control group (p=0.01, p=0.0004, p =0.001, respectively). However, postoperative blood loss and the rate of reexploration for bleeding were similar in the two groups. The patients receiving blood products were fewer in the autotransfusion group than those in the control group (21% vs 44%; p=0.005). Autotransfusion did not increase postoperative complications, including infection. Thus, although autotransfusion of mediastinal shed blood has the potential to affect hemostasis, unless the amount of autotransfusion exceeds 800 ml, it appears that this method is clinically safe and effective as a mean of blood conservation.
Similar content being viewed by others
References
Schaff HV, Hauer JM, Bell WR, et al: Autotransfusion of shed mediastinal blood after cardiac surgery. A prospective study. J Thorac Cardiovasc Surg 75: 632–641, 1978.
Hardy JF, Bélisle S, Janvier G, Samama M: Reduction in requirements for allogenic blood products: Nonpharmacologic methods. Ann Thorac Surg 62: 1935–1943, 1996
Øvrum E, Holen EÅ, Abdelnoor M, Øystese R: Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. Ann Thorac Surg 52: 500–505, 1991
42: 499–507, 1994
Griffith LD, Billman GF, Daily PO, Lane TA: Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg 47: 400–406, 1989
De Haan J, Schönberger J, Haan J, Oeveren W, Eijgelaar A: Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. J Thorac Cardiovasc Surg 106: 1017–1023, 1993
Vertrees RA, Conti VR, Lick SD, Swiscenberger JB, MvDaniel LB, Shulman G: Adverse effects of postoperative infusion of shed mediastinal blood. Ann Thorac Surg 62: 717–723, 1996
Schönberger JPAM, Oeveren W, Bredée JJ, Everts PAM, Hann J, Wildevuur CRH: Systemic blood activation during and after autotransfusion. Ann Thorac Surg 57: 1256–1262, 1994
Johnson RG, Rosenkrantz KR, Preston RA, Hopkins C, Daggett WM: The efficacy of postoperative autotransfusion in patients undergoing cardiac operations. Ann Thorac Surg 36: 173–179, 1983
Ward HB, Smith RRA, Landis KP, Nemzek TG, Dalmasso AP, Swaim WR: Prospective, randomized trial of autotransfusion after routine cardiac operations. Ann Thorac Surg 56: 137–141, 1993
42: 1123–1131, 1994
Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM, Goel IP: Prophylactic tranexamic acid decrease bleeding after cardiac operations. J Thorac Cardiovasc Surg 99: 70–74, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Komiya, T., Ban, K., Yamazaki, K. et al. Blood conservation effect and safety of shed mediastinal blood autotransfusion after cardiac surgery. Jpn J Thorac Caridovasc Surg 46, 961–965 (1998). https://doi.org/10.1007/BF03217855
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03217855